Traws Pharma's market cap is currently $13.07M. The company's EPS TTM is $-0.11; its P/E ratio is 0.12; Traws Pharma is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
